Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-767-9 | CAS number: 99-57-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Ames assay
Test chemical was evaluated for its mutagenic potential in Salmonella typhimurium TA100, TA1535, TA98 and TA1537 by AMES test. The test result was considered to be positive in all strain in the presence and absence of metabolic activation S9.
In vitro chromosomal abbreviation study
Test chemical was evaluated for its mutagenic potential in Chinese hamster ovary cells by in vitro mammalian chromosome aberration test. The test result was considered to be mutagenic both in the presence and absence of metabolic activation.
In vitro Mammalian cell gene mutation assay
Test chemical was evaluated for its mutagenic potential in mouse lymphoma by in vitro mammalian cell gene mutation. The test result was considered to be positive in Mouse lymphoma.
In vitro DNA damage and/or repair study
Test chemical was evaluated for its mutagenic potential in Chinese hamster ovary cells in vitro sister chromatid exchange assay. The test result was considered to be mutagenic both in the presence and absence of metabolic activation.
.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- data from handbook or collection of data
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Principles of method if other than guideline:
- To evaluate the mutagenic potential of test chemical in Salmonella Typhimurium TA98,TA 100,TA 1535 and TA 1537 by AMES test.
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Histidine
- Species / strain / cell type:
- S. typhimurium, other: TA98,TA 100,TA 1535 and TA 1537
- Details on mammalian cell type (if applicable):
- not specified
- Additional strain / cell type characteristics:
- not specified
- Cytokinesis block (if used):
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- RLI = induced male Sprague Dawley rat liver S9 HLI = induced male Syrian hamster liver S9
- Test concentrations with justification for top dose:
- 0,10,30,100, 333,1000 and 3333µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: 95% Ethanol
- Justification for choice of solvent/vehicle: The test substance is soluble in 95% Ethanol. - Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- 95% Ethanol
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- other: -S9 mix;4 nitro-O phenylenediamine (TA 98), Sodium azide (TA1535and TA 100) and 9-Aminoacridine(TA1537) +S9 mix; 2-Aminoanthracene(all strains)
- Details on test system and experimental conditions:
- Details on test system and conditions
METHOD OF APPLICATION: Pre incubation method
NUMBER OF REPLICATIONS: Duplicate - Evaluation criteria:
- The plates were observed for revertents mutants colonies per plates
- Statistics:
- Yes, SD ± Mean was observed.
- Key result
- Species / strain:
- S. typhimurium, other: TA100, TA1535, TA98 and TA1537
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- other: Mutagenic effect were observed
- Conclusions:
- Test chemical was evaluated for its mutagenic potential in Salmonella typhimurium TA100, TA1535, TA98 and TA1537 by AMES test. The test result was considered to be positive in all strain in the presence and absence of metabolic activation S9.
- Executive summary:
Genetic toxicity in vitro study was assessed for test chemical. For this purpose AMES test was performed .The test material was exposed to Salmonella typhimurium TA100, TA1535, TA98 and TA1537in the presence and absence of metabolic activation S9. The concentration of test material used in the presence and absence of metabolic activation were 0, 10, 30,100, 333, 1000 and 3333 µg/plate. Mutagenic effects were observed in all strains, in the presence and absence of metabolic activation. Therefore test chemical was considered to be mutagenic in Salmonella typhimurium TA100, TA1535, TA98 and TA1537by AMES test. Hence the substance can be classified as gene mutant in vitro.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- data from handbook or collection of data.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Principles of method if other than guideline:
- To evaluate the mutagenic potential of test chemical in Chinese hamster ovary cells by in vitro mammalian chromosome aberration test.
- GLP compliance:
- not specified
- Type of assay:
- other: in vitro mammalian chromosome aberration test
- Target gene:
- Not specified
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- not specified
- Additional strain / cell type characteristics:
- not specified
- Cytokinesis block (if used):
- not specified
- Metabolic activation:
- with and without
- Metabolic activation system:
- induced male Sprague Dawley rat liver S9
- Test concentrations with justification for top dose:
- -S9;0,150,199,249and 300 µg/mL
+S9; 0,2460,2760,2990 and 3520 µg/mL - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Dimethyl Sulfoxide
- Justification for choice of solvent/vehicle: The test substance is soluble in DMSO. - Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- other: -S9 mix; Mitomycin-C +S9 mix; Cyclophosphamide
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: In medium
DURATION
- Fixation time (start of exposure up to fixation or harvest of cells): 20.8 hours
NUMBER OF CELLS EVALUATED: 100 cells - Evaluation criteria:
- The mammalian cells were observed for chromosome aberration, Chromosome gaps and breaks.
- Statistics:
- Yes, SD ± Mean was observed.
- Key result
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- other: Mutagenic effects were observed
- Conclusions:
- Test chemical was evaluated for its mutagenic potential in Chinese hamster ovary cells by in vitro mammalian chromosome aberration test. The test result was considered to be mutagenic both in the presence and absence of metabolic activation.
- Executive summary:
Genetic toxicity in vitro study was assessed for test chemical. For this purpose in vitro mammalian chromosome aberration test was performed .The test material was exposed toChinese hamster ovary cells inthe presence and absence of metabolic activation S9. The concentration of test material used in the presence and absence of metabolic activation were mention below
-S9;0,150,199,249and 300 µg/mL
+S9; 0,2460,2760,2990 and 3520 µg/mL
Chromosome aberration, Chromosome gaps and breaks were observed in the presence or absence of metabolic activation. Therefore test chemical was considered to be mutagenic inChinese hamster ovary cells byin vitro mammalian chromosome aberration test. Hence the substance cannot be classified as mutagenic in vitro.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- data from handbook or collection of data
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Principles of method if other than guideline:
- To evaluate the mutagenic potential of test chemical in mouse lymphoma by in vitro mammalian cell gene mutation.
- GLP compliance:
- not specified
- Type of assay:
- other: in vitro mammalian cell gene mutation test
- Target gene:
- Not specified
- Species / strain / cell type:
- other: mouse lymphoma cells
- Details on mammalian cell type (if applicable):
- not specified
- Additional strain / cell type characteristics:
- not specified
- Cytokinesis block (if used):
- not specified
- Metabolic activation:
- not specified
- Test concentrations with justification for top dose:
- Experiment I; 0,25,50,100,150,200 and 300 µg/mL
Experiment II: 50,100,150,200 and 300 µg/mL - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Dimethyl Sulfoxide
- Justification for choice of solvent/vehicle: The test substance is soluble in DMSO. - Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- other: Methyl Methane Sulfonate
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: In culture dish
DETERMINATION OF CYTOTOXICITY; relative total growth - Evaluation criteria:
- The mammalian cells were observed for mutagenic frequency in cells.
- Statistics:
- Yes, SD ± Mean was observed.
- Key result
- Species / strain:
- other: mouse lymphoma cells
- Metabolic activation:
- not specified
- Genotoxicity:
- positive
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- other: Mutagenic effects were observed
- Conclusions:
- Test chemical was evaluated for its mutagenic potential in mouse lymphoma by in vitro mammalian cell gene mutation. The test result was considered to be positive in Mouse lymphoma.
- Executive summary:
Genetic toxicity in vitro study was assessed for test chemical. For this purpose in vitro mammalian cell gene mutation was performed .The test material was exposed to mouse lymphoma cells.The concentration of test material used in two experiment were mention below
Experiment I; 0,25,50,100,150,200 and 300 µg/mL
Experiment II: 50,100,150,200 and 300 µg/mL
Mutagenic frequency were observed in the mammalian cells. Therefore test chemical was considered to bemouse lymphoma byin vitro mammalian cell gene mutation. Hence the substance can be classified as mutagenic in vitro.
Referenceopen allclose all
Strain: TA100 |
||||||||||||
|
||||||||||||
Dose |
No Activation |
No Activation |
10% RLI |
10% RLI |
10% HLI |
10% HLI |
||||||
Protocol |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
||||||
ug/Plate |
Mean |
±SEM |
Mean |
±SEM |
Mean |
±SEM |
Mean |
±SEM |
Mean |
±SEM |
Mean |
±SEM |
0 |
139 |
7.8 |
107 |
4 |
142 |
4.3 |
112 |
7.9 |
129 |
6.9 |
163 |
8.8 |
10 |
121 |
5.4 |
146 |
3.2 |
||||||||
33 |
135 |
9.5 |
114 |
4.7 |
133 |
4.9 |
162 |
7.7 |
164 |
10.3 |
156 |
8.4 |
100 |
145 |
8.4 |
117 |
11.8 |
132 |
14.2 |
169 |
10.2 |
210 |
8.7 |
223 |
11 |
333 |
142 |
6.2 |
101 |
7.4 |
134 |
10 |
191 |
6.4 |
268 |
2.9 |
247 |
9 |
1000 |
146 |
10.3 |
97 |
11.6 |
122 |
2.7 |
180 |
3.5 |
289 |
17.3 |
282 |
5.9 |
3333 |
86 s |
49.7 |
t |
0 s |
0 |
0 s |
0 |
|||||
Positive Control |
434 |
3.7 |
407 |
18.7 |
690 |
15.4 |
551 |
3.5 |
1290 |
45.3 |
1796 |
23.7 |
Strain: TA1535 |
||||||
Dose |
No Activation |
10% RLI |
10% HLI |
|||
Protocol |
Preincubation |
Preincubation |
Preincubation |
|||
ug/Plate |
Mean |
±SEM |
Mean |
±SEM |
Mean |
±SEM |
0 |
27 |
.9 |
46 |
3.8 |
42 |
4.5 |
33 |
29 |
3.7 |
28 |
1.7 |
41 |
2.1 |
100 |
25 |
3.5 |
21 |
1.8 |
36 |
.3 |
333 |
27 |
3 |
16 |
1.2 |
37 |
2.2 |
1000 |
28 |
5.2 |
0 s |
0 |
32 |
3.5 |
3333 |
9 s |
3.1 |
t |
0 s |
0 |
|
Positive Control |
427 |
7.1 |
277 |
7.1 |
536 |
12.8 |
Strain: TA1537 |
||||||
Dose |
No Activation |
10% RLI |
10% HLI |
|||
Protocol |
Preincubation |
Preincubation |
Preincubation |
|||
ug/Plate |
Mean |
±SEM |
Mean |
±SEM |
Mean |
±SEM |
0 |
5 |
.9 |
10 |
1 |
5 |
.6 |
33 |
6 |
1 |
7 |
1.2 |
12 |
2.8 |
100 |
6 |
1.7 |
7 |
.9 |
12 |
4 |
333 |
6 |
.3 |
11 |
1.2 |
15 |
1.3 |
1000 |
10 |
2 |
12 |
2.3 |
10 |
2 |
3333 |
5 |
.3 |
9 |
1.7 |
0 s |
0 |
Positive Control |
172 |
4.7 |
167 |
14.8 |
500 |
5.5 |
Strain: TA98 |
||||||||||||
Dose |
No Activation |
No Activation |
10% RLI |
10% RLI |
10% HLI |
10% HLI |
||||||
Protocol |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
Preincubation |
||||||
ug/Plate |
Mean |
±SEM |
Mean |
±SEM |
Mean |
±SEM |
Mean |
±SEM |
Mean |
±SEM |
Mean |
±SEM |
0 |
21 |
2 |
29 |
2.2 |
40 |
1.7 |
37 |
3.5 |
37 |
3.7 |
37 |
4.3 |
10 |
27 |
1.5 |
44 |
1.3 |
||||||||
33 |
26 |
3.1 |
52 |
7.2 |
38 |
4.2 |
53 |
.7 |
50 |
3 |
54 |
3.2 |
100 |
30 |
2.7 |
64 |
4.6 |
50 |
2.3 |
57 |
1.9 |
67 |
3.6 |
62 |
3.7 |
333 |
17 |
2.3 |
64 |
6.6 |
55 |
3.5 |
75 |
6.8 |
94 |
4.7 |
86 |
.3 |
1000 |
17 |
1 |
84 |
7.1 |
56 |
4.7 |
83 |
1.2 |
242 |
19.6 |
113 |
13.5 |
3333 |
t |
0 s |
0 |
t |
0 s |
0 |
||||||
Positive Control |
724 |
34 |
724 |
7.1 |
425 |
15.3 |
382 |
27 |
1514 |
107.5 |
1027 |
53.1 |
Abbreviations:
RLI =
induced male Sprague Dawley rat liver S9
HLI = induced male Syrian hamster liver S9
s = Slight Toxicity; p = Precipitate; x = Slight Toxicity and
Precipitate; t = Toxic;
|
Total |
Total Aberrations |
Complex Aberrations |
Simple Aberrations |
Other Abs |
||||||||||
No.of |
Abs |
% Cells |
No.of |
Abs |
% Cells |
No.of |
Abs |
% Cells |
No.of |
Abs |
% Cells |
||||
Vehicle Control: |
Negative (Not Specified) |
0 |
100 |
2 |
0.020 |
2.0 |
2 |
0.020 |
2.0 |
0 |
0.000 |
0.0 |
0 |
0.000 |
0.0 |
Dimethyl Sulfoxide |
0 |
100 |
2 |
0.020 |
2.0 |
2 |
0.020 |
2.0 |
0 |
0.000 |
0.0 |
0 |
0.000 |
0.0 |
|
Test Chemical: |
2-Amino-4-nitrophenol |
150 |
100 |
12 |
0.120 |
3.0 |
0 |
0.000 |
0.0 |
1 |
0.010 |
1.0 |
11 |
0.110 |
2.0 |
199 |
100 |
7 |
0.070 |
6.0 |
4 |
0.040 |
4.0 |
2 |
0.020 |
2.0 |
1 |
0.010 |
1.0 |
||
249 |
100 |
12 |
0.120 |
11.0 |
6 |
0.060 |
6.0 |
3 |
0.030 |
3.0 |
3 |
0.030 |
3.0 |
||
300 |
0 |
0 |
0.000 |
0.0 |
0 |
0.000 |
0.0 |
0 |
0.000 |
0.0 |
0 |
0.000 |
0.0 |
||
Positive Control: |
Mitomycin-C |
0.0625 |
50 |
18 |
0.360 |
26.0 |
16 |
0.320 |
24.0 |
2 |
0.040 |
4.0 |
0 |
0.000 |
0.0 |
Trend: |
2.934 |
2.134 |
1.838 |
|
|||||||||||
Probability: |
0.002 |
0.016 |
0.033 |
|
Trial #:1_S9 Activation: Induced Rat Liver S9 Date: 03/10/1983 Harvest Time: 20.8 hour(s) Trial Call: Positive |
||||||||||||||||
|
Dose |
Total |
Total Aberrations |
Complex Aberrations |
Simple Aberrations |
Other Abs |
|
|||||||||
No.of |
Abs |
% Cells |
No.of |
Abs |
% Cells |
No.of |
Abs |
% Cells |
No.of |
Abs |
% Cells |
|
||||
Vehicle Control: |
Negative (Not Specified) |
0 |
100 |
2 |
0.020 |
2.0 |
1 |
0.010 |
1.0 |
0 |
0.000 |
0.0 |
1 |
0.010 |
1.0 |
|
Dimethyl Sulfoxide |
0 |
100 |
1 |
0.010 |
1.0 |
0 |
0.000 |
0.0 |
0 |
0.000 |
0.0 |
1 |
0.010 |
1.0 |
|
|
Test Chemical: |
2-Amino-4-nitrophenol |
2460 |
100 |
14 |
0.140 |
5.0 |
1 |
0.010 |
1.0 |
1 |
0.010 |
1.0 |
12 |
0.120 |
3.0 |
|
2760 |
100 |
103 |
1.030 |
28.0 |
35 |
0.350 |
19.0 |
15 |
0.150 |
11.0 |
53 |
0.530 |
8.0 |
|
||
2990 |
50 |
74 |
1.480 |
34.0 |
16 |
0.320 |
18.0 |
6 |
0.120 |
10.0 |
52 |
1.040 |
14.0 |
|
||
3520 |
0 |
0 |
0.000 |
0.0 |
0 |
0.000 |
0.0 |
0 |
0.000 |
0.0 |
0 |
0.000 |
0.0 |
|
||
Positive Control: |
Cyclophosphamide |
10 |
50 |
10 |
0.200 |
18.0 |
6 |
0.120 |
12.0 |
4 |
0.080 |
8.0 |
0 |
0.000 |
0.0 |
|
Trend: |
6.835 |
5.479 |
3.964 |
|
|
|||||||||||
Probability: |
0.000 |
0.000 |
0.000 |
|
Nonactivation Trial: 1 Experiment Call: Positive |
|||||||
|
Conc. |
Cloning |
Relative Total |
Mutant Colonies |
Mutant Frequency |
Avg Mutant Frequency |
|
Vehicle Control |
Dimethyl Sulfoxide |
0 |
111 |
101 |
122 |
37 |
43 |
|
|
90 |
103 |
144 |
53 |
||
|
|
75 |
101 |
94 |
42 |
||
|
|
110 |
94 |
126 |
38 |
||
Test Chemical |
2-Amino-4-nitrophenol |
25 |
70 |
53 |
198 |
94 |
98* |
|
|
61 |
53 |
209 |
114 |
||
|
|
52 |
62 |
134 |
85 |
||
|
50 |
72 |
53 |
233 |
109 |
108* |
|
|
|
64 |
54 |
193 |
100 |
||
|
|
61 |
50 |
211 |
115 |
||
|
100 |
65 |
27 |
349 |
179 |
194* |
|
|
|
54 |
20 |
320 |
198 |
||
|
|
48 |
20 |
296 |
206 |
||
|
150 |
63 |
4 |
501 |
266 |
271* |
|
|
|
47 |
4 |
422 |
299 |
||
|
|
50 |
10 |
370 |
248 |
||
|
200 |
273* |
|||||
|
|
46 |
4 |
366 |
267 |
||
|
|
52 |
3 |
433 |
278 |
||
|
300 |
||||||
|
|
||||||
|
|
||||||
Positive Control |
Methyl Methane Sulfonate |
5 |
65 |
60 |
508 |
260 |
258* |
|
|
77 |
26 |
598 |
258 |
||
|
|
65 |
60 |
503 |
257 |
Nonactivation Trial: 2 Experiment Call: Positive |
|||||||
|
Conc. |
Cloning |
Relative Total |
Mutant Colonies |
Mutant Frequency |
Avg Mutant Frequency |
|
Vehicle Control |
Dimethyl Sulfoxide |
0 |
93 |
90 |
98 |
35 |
29 |
|
|
121r |
126 |
92 |
25 |
||
|
|
109 |
117 |
84 |
26 |
||
|
|
111 |
93 |
89 |
27 |
||
Test Chemical |
2-Amino-4-nitrophenol |
50 |
69 |
43 |
141 |
69 |
71* |
|
|
77 |
42 |
177 |
77 |
||
|
|
93 |
51 |
192 |
69 |
||
|
75 |
114 |
57 |
251 |
74 |
73* |
|
|
|
79 |
44 |
165 |
70 |
||
|
|
73 |
40 |
164 |
75 |
||
|
100 |
92 |
24 |
206 |
75 |
82* |
|
|
|
89 |
36 |
243 |
91 |
||
|
|
87 |
32 |
208 |
80 |
||
|
150 |
93 |
17 |
365 |
131 |
118* |
|
|
|
86 |
20 |
280 |
108 |
||
|
|
67 |
20 |
230 |
115 |
||
|
200 |
86 |
18 |
287 |
111 |
133* |
|
|
|
68 |
6 |
315 |
156 |
||
|
|
91 |
10 |
360 |
133 |
||
|
300 |
100 |
8 |
393 |
131 |
143* |
|
|
|
67 |
5 |
295 |
148 |
||
|
|
76 |
5 |
344 |
152 |
||
Positive Control |
Methyl Methane Sulfonate |
5 |
57 |
46 |
605 |
357 |
335* |
|
|
58 |
34 |
670 |
382 |
||
|
|
75 |
62 |
592 |
265 |
Footnotes:
Asterisks(*) indicate significant responses.
r = rejected value due to quality control criteria
# = reduced sample size because of the loss of one culture dish due to
contamination
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (positive)
Genetic toxicity in vivo
Description of key information
Test substance was evaluated for its mutagenic potential in male Mouse and rat by In vivo Mammalian Somatic cell study. The test result was consider to be negative as there was no significant chromosome damage in micronucleated polychromatic erythrocytes.
Link to relevant study records
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- data from handbook or collection of data
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Principles of method if other than guideline:
- To evaluate the mutagenic potential of test chemical in B6C3F1 male Mouse by In vivo Mammalian Somatic cell study.
- GLP compliance:
- not specified
- Type of assay:
- other: In vivo Mammalian Somatic cell study.
- Species:
- mouse
- Strain:
- B6C3F1
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Not specified
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: Corn oil
- Duration of treatment / exposure:
- 72 hour
- Frequency of treatment:
- 3 times in 72 hours
- Remarks:
- 0,4.687,9.375,18.75,37.5,75,150 and 300 mg/Kg
- No. of animals per sex per dose:
- 5 animals per sex per dose
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Positive controls; Cyclophosphamide
- Route of administration: Intraperitoneal Injection
- Doses / concentrations:25 mg/kg - Tissues and cell types examined:
- Bone Marrow cells were examined.
- Evaluation criteria:
- An increase in the frequency of micronucleated polychromatic erythrocytes in treated animals is an indication of induced chromosome damage.
- Statistics:
- Yes SD± Mean was observed.
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- not specified
- Vehicle controls validity:
- valid
- Negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- other: No mutagenic effect were observed
- Conclusions:
- Test substance was evaluated for its mutagenic potential in B6C3F1 male Mouse by In vivo Mammalian Somatic cell study. The test result was consider to be negative as there was no significant chromosome damage in micronucleated polychromatic erythrocytes.
- Executive summary:
In the study test substance was assessed for its possible mutagenic potential. For this purpose wasIn vivo Mammalian Somatic cell study in B6C3F1 male Mouse. The test substance was administrated by Intraperitoneal Injection by using corn oil as vehicle. The test substance was exposed at the concentration of 0, 4.687, 9.375, 18.75, 37.5,75,150 and 300 mg/Kg for 72 hours. The dose was administrated thrice in 72 hours .The bone marrow cells were stained and observed for chromosome damage. No significant increase in the frequency of micronucleated polychromatic erythrocytes in treated animals was observed. Therefore test result was consider to be negative as there was no significant chromosome damage in micronucleated polychromatic erythrocytes. Hence the substance cannot be classified as mutant In Vivo.
Reference
Vehicle Control |
Corn Oil |
0 |
5 |
0.700 ± 0.250 |
|
Test Chemical |
2-Amino-4-nitrophenol |
4.687 |
5 |
0.900 ± 0.290 |
0.309 |
9.375 |
4 |
1.250 ± 0.320 |
0.116 |
||
18.75 |
5 |
2.100 ± 0.480 |
0.004 |
||
37.5 |
5 |
1.700 ± 0.250 |
0.021 |
||
75 |
4 |
1.750 ± 0.520 |
0.020 |
||
150 |
5 |
1.100 ± 0.240 |
0.173 |
||
300 |
2 |
1.000 ± 0.500 |
0.284 |
||
Positive Control |
Cyclophosphamide |
25 |
5 |
16.200 ± 0.800 |
Value less than 0.0001 |
|
Dose (mg/kg) |
Number of Animals Scored |
Mean Percent PCE ± SEM |
Pairwise P |
|
Vehicle Control |
Corn Oil |
0 |
5 |
41.170 ± 2.800 |
|
Test Chemical |
2-Amino-4-nitrophenol |
4.687 |
5 |
40.130 ± 2.570 |
|
9.375 |
4 |
44.000 ± 1.640 |
|||
18.75 |
5 |
42.830 ± 3.470 |
|||
37.5 |
5 |
42.120 ± 2.510 |
|||
75 |
4 |
44.330 ± 2.950 |
|||
150 |
5 |
40.200 ± 3.900 |
|||
300 |
2 |
32.700 ± 8.500 |
|||
Positive Control |
Cyclophosphamide |
25 |
5 |
43.200 ± 2.660 |
|
Dose (mg/kg) |
Number of Animals Scored |
Mean MN-PCE/1000 PCE ± SEM |
Pairwise P |
|
Vehicle Control |
Corn Oil |
0 |
5 |
1.100 ± 0.190 |
|
Test Chemical |
2-Amino-4-nitrophenol |
18.75 |
5 |
1.300 ± 0.250 |
0.342 |
37.5 |
5 |
1.600 ± 0.190 |
0.168 |
||
75 |
5 |
1.100 ± 0.240 |
0.500 |
||
150 |
5 |
0.700 ± 0.250 |
0.827 |
||
Positive Control |
Cyclophosphamide |
25 |
5 |
13.100 ± 0.830 |
Value less than 0.0001 |
|
Dose (mg/kg) |
Number of Animals Scored |
Mean Percent PCE ± SEM |
Pairwise P |
|
Vehicle Control |
Corn Oil |
0 |
5 |
46.200 ± 0.000 |
|
Test Chemical |
2-Amino-4-nitrophenol |
18.75 |
5 |
54.840 ± 1.200 |
|
37.5 |
5 |
44.600 ± 0.510 |
|||
75 |
5 |
58.640 ± 1.920 |
|||
150 |
5 |
57.320 ± 1.330 |
|||
Positive Control |
Cyclophosphamide |
25 |
5 |
46.960 ± 1.900 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Data for the various publication was reviewed to determine the mutagenic nature of 2-amino-4-nitrophenol (99-57-0). The studies are as mentioned below:
In Vitro studies
Ames assay
Genetic toxicity in vitro study was assessed for test chemical. For this purpose AMES test was performed .The test material was exposed to Salmonella typhimurium TA100, TA1535, TA98 and TA1537in the presence and absence of metabolic activation S9. The concentration of test material used in the presence and absence of metabolic activation were 0, 10, 30,100, 333, 1000 and 3333 µg/plate. Mutagenic effects were observed in all strains, in the presence and absence of metabolic activation. Therefore test chemical was considered to be mutagenic in Salmonella typhimurium TA100, TA1535, TA98 and TA1537by AMES test. Hence the substance can be classified as gene mutant in vitro.
Supported by other AMES test. Genetic toxicity in vitro study was assessed for test chemical. For this purpose AMES test was performed .The test material was exposed to Salmonella typhimurium TA100, TA1535, TA98 and TA1537in the presence and absence of metabolic activation S9. The concentration of test material used in the presence and absence of metabolic activation were 0, 10, 30,100, 333, 1000 and 3333 µg/plate. Mutagenic effects were observed in all strains, in the presence and absence of metabolic activation. Therefore test chemical was considered to be mutagenic in Salmonella typhimurium TA100, TA1535, TA98 and TA1537by AMES test. Hence the substance can be classified as gene mutant in vitro.
In vitro chromosomal abbreviation study
Genetic toxicity in vitro study was assessed for test chemical. For this purpose in vitro mammalian chromosome aberration test was performed .The test material was exposed toChinese hamster ovary cells inthe presence and absence of metabolic activation S9. The concentration of test material used in the presence and absence of metabolic activation were mention below
-S9;0,150,199,249and 300 µg/mL
+S9; 0,2460,2760,2990 and 3520 µg/mL
Chromosome aberration, Chromosome gaps and breaks were observed in the presence or absence of metabolic activation. Therefore test chemical was considered to be mutagenic inChinese hamster ovary cells byin vitro mammalian chromosome aberration test. Hence the substance cannot be classified as mutagenic in vitro.
In vitro Mammalian cell gene mutation assay
Genetic toxicity in vitro study was assessed for test chemical. For this purpose in vitro mammalian cell gene mutation was performed .The test material was exposed to mouse lymphoma cells.The concentration of test material used in two experiment were mention below
Experiment I; 0,25,50,100,150,200 and 300 µg/mL
Experiment II: 50,100,150,200 and 300 µg/mL
Mutagenic frequency were observed in the mammalian cells. Therefore test chemical was considered to be mutagenic in mouse lymphoma by in vitro mammalian cell gene mutation. Hence the substance can be classified as mutagenic in vitro.
In vitro DNA damage and/or repair study
Genetic toxicity in vitro study was assessed for test chemical. For this purpose in vitro sister chromatid exchange assay was performed .The test material was exposed toChinese hamster ovary cells inthe presence and absence of metabolic activation S9. The concentration of test material used in the presence and absence of metabolic activation were mention below
-S9;0,5,16.7 and 50 µg/mL
+S9; 0,1740,2180 and 2670 µg/mL
The mammalian cells were observed fornumber of scored exchanges correlates to the number of DNA breakage and reunion eventsin the presence or absence of metabolic activation. The test article induced sister chromatid exchange in the cultured cells. Therefore test chemical was considered to be mutagenic inChinese hamster ovary cells byin vitro sister chromatid exchange assay. Hence the substance cannot be classified as mutagenic in vitro.
In Vivo studies
In the study test substance was assessed for its possible mutagenic potential. For this purpose wasIn vivo Mammalian Somatic cell study in B6C3F1 male Mouse. The test substance was administrated by Intraperitoneal Injection by using corn oil as vehicle. The test substance was exposed at the concentration of 0, 4.687, 9.375, 18.75, 37.5,75,150 and 300 mg/Kg for 72 hours. The dose was administrated thrice in 72 hours .The bone marrow cells were stained and observed for chromosome damage. No significant increase in the frequency of micronucleated polychromatic erythrocytes in treated animals was observed. Therefore test result was consider to be negative as there was no significant chromosome damage in micronucleated polychromatic erythrocytes. Hence the substance cannot be classified as mutant In Vivo.
In the study test substance was assessed for its possible mutagenic potential. For this purpose wasIn vivo Mammalian Somatic cell study in Fischer 344 male rat. The test substance was administrated by Intraperitoneal Injection by using corn oil as vehicle. The test substance was exposed at the concentration of 0, 3.91, 7.815, 15.63, 31.25, 62.5 and 125 mg/Kg for 72 hours. The dose was administrated thrice in 72 hours .The bone marrow cells were stained and observed for chromosome damage. No significant increase in the frequency of micronucleated polychromatic erythrocytes in treated animals was observed. Therefore test result was consider to be negative as there was no significant chromosome damage in micronucleated polychromatic erythrocytes. Hence the substance cannot be classified as mutant In Vivo.
Based on the data summarized, 2-amino-4-nitrophenol (99-57-0)did not induce gene mutation in vivo while it induce gene mutation in vitro.The test chemical induce mutation in AMES test as well as in OECD 473 test (In vitro chromosomal abbreviation study) . The test chemical induce gene mutation in In vitro Mammalian cell gene mutation assay too. But as the test chemical did not induce gene mutatiomn in IN vivo study conducted in male rat and male mouse.As per CLP criteria
The classification in Category 2 is based on:
— positive evidence obtained from experiments in mammals and/or in some cases from in vitro experiments, obtained from:
— somatic cell mutagenicity tests in vivo, in mammals; or
— other in vivo somatic cell genotoxicity tests which are supported by positive results from in vitro mutagenicity assays.
Hence based on CLP criteria the test substance can not be classified as mutagenic.
Justification for classification or non-classification
Based on the data summarized and CLP criteria , 2-amino-4-nitrophenol (99-57-0) not likly induce gene mutation in vivo while it induce gene mutation in vitro.The test chemical induce mutation in AMES test as well as in OECD 473 test (In vitro chromosomal abbreviation study) .
The test chemical induce gene mutation in In vitro Mammalian cell gene mutation assay too.
But as the test chemical did not induce gene mutatiomn in In vivo study conducted in male rat and male mouse.As per CLP criteria
The classification in Category 2 is based on:
— positive evidence obtained from experiments in mammals and/or in some cases from in vitro experiments, obtained from:
— somatic cell mutagenicity tests in vivo, in mammals; or
— other in vivo somatic cell genotoxicity tests which are supported by positive results from in vitro mutagenicity assays.
As no evidence of somatic cell mutagenicity tests in vivo, in mammalswas observed
Hence based on CLP criteria the test substance not likly to be be classified as mutagen.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.